Log In Help Join The Motley Fool

Corinne Cardina Jurney

TMFccardina

Recent Articles by Corinne Cardina Jurney

INTERVIEW_Omid_Farokhzad

Jun 25, 2021 by Corinne Cardina Jurney

CEO of Newly IPO'd Seer: For Biotech Investors, Proteins Are The New DNA

Seer's CEO Dr. Omid Farokhzad describes the revolutionary potential in the proteomics sector and what investors should know.

INTERVIEW_Walter_Isaacson

Mar 10, 2021 by Corinne Cardina Jurney

Walter Isaacson, Author of 'The Code Breaker,' On Dr. Jennifer Doudna And CRISPR Gene Editing

The renowned biographer's new book profiles one of the two women who won the 2020 Nobel Prize in Chemistry for their role in discovering CRISPR gene editing.

GettyImages-1187321840

Mar 2, 2021 by Corinne Cardina Jurney and Nick Sciple

Facebook's COVID Strategy: Promoting Accurate Information Vs. Attacking Misinformation

The social media giant has a new campaign aimed at building trust in vaccines and taking down debunked health claims.

GettyImages-1208620496

Mar 1, 2021 by Corinne Cardina Jurney and Nick Sciple

Facebook Stock and Antitrust Regulation: What Should Investors Know?

Could regulators break up Facebook and what would that mean for investors?

GettyImages-168580604

Mar 1, 2021 by Corinne Cardina Jurney and Nick Sciple

Facebook's Antitrust Headaches: Monopoly or Duopoly?

Could regulators break up Facebook and what would that mean for investors?

GettyImages-1213930057

Mar 1, 2021 by Corinne Cardina Jurney and Nick Sciple

How Facebook's Coronavirus Work Shows Its Importance In The World

Why investors should care that the social media giant unveiled a campaign aimed at increasing trust in COVID vaccines.

GettyImages-1281768404

Mar 1, 2021 by Corinne Cardina Jurney

Why Facebook Is Removing False Claims About COVID and Vaccines

KX Jin explains Facebook's strategy of promoting accurate information about the pandemic and removing debunked claims.

GettyImages-1272700635

Feb 28, 2021 by Corinne Cardina Jurney and Nick Sciple

How Ad Revenue Powers Facebook's Entire Business

All of Facebook's platforms are free to use, but it's still the king of profiting from its users.

GettyImages-1138315661

Feb 28, 2021 by Corinne Cardina Jurney and Nick Sciple

How Facebook Beats Pinterest And Snapchat At User Monetization

All of Facebook's platforms are free to use, but it's still the king of profiting from its users.

GettyImages-1225899286

Feb 28, 2021 by Corinne Cardina Jurney

Facebook's Head of Health: "Misinformation Really Thrives In the Absence of Credible Information"

KX Jin explains Facebook's strategy of promoting accurate information about the pandemic and removing debunked health claims.

GettyImages-537971779

Feb 28, 2021 by Corinne Cardina Jurney and Nick Sciple

Antitrust Regulation And Facebook: We're in a Brave New World

Could regulators break up Facebook and what would that mean for investors?

GettyImages-1184784735

Feb 28, 2021 by Corinne Cardina Jurney

How Facebook Is Using Its Data For Good in the Coronavirus Pandemic

Facebook's Head of Health KX Jin describes how the social media giant is supporting local COVID responses.

GettyImages-1277861476

Feb 28, 2021 by Corinne Cardina Jurney

Can Facebook Help You Get Vaccinated?

We spoke with Facebook's Head of Health KX Jin about the social media giant's new campaign to help users find out when and where they can get their COVID vaccine.

GettyImages-1182694703

Feb 27, 2021 by Corinne Cardina Jurney and Nick Sciple

Facebook Had Its Worst Quarter Ever In 2020, But Revenue Was Still Up 10%

How did the ad-dependent social media giant thrive in a year when a pandemic and recession made for challenging conditions?

GettyImages-1252396999

Feb 27, 2021 by Corinne Cardina Jurney and Nick Sciple

Is The Market Mispricing The Opportunity For Virtual Reality?

Facebook's Oculus is an oft-forgotten part of its business, but the upside is underrated.

GettyImages-520359380

Feb 27, 2021 by Corinne Cardina Jurney and Nick Sciple

Facebook Investor Peter Thiel: Why Monopolies Pretend to Be In Incredible Competition

Could regulators break up Facebook and what would that mean for investors?

GettyImages-1284041821

Feb 27, 2021 by Corinne Cardina Jurney and Nick Sciple

How Are Twitter And Facebook Dealing With COVID Misinformation?

Here's how social media giants are handling posts with debunked health claims, particularly around vaccines.

GettyImages-1165048144

Feb 27, 2021 by Corinne Cardina Jurney and Nick Sciple

Facebook Vs. Apple: War Of The Tech Giants

Why are two of the most powerful companies at odds with each other and what's at stake

GettyImages-1189729358

Feb 27, 2021 by Corinne Cardina Jurney

Why Facebook Has a Health Team Working On COVID Issues (Including Vaccines)

Facebook's Head of Health KX Jin explains why he's focused on providing users with accurate and local vaccine information.

INTERVIEW_KX_Jin

Mar 1, 2021 by Corinne Cardina Jurney

How Facebook Is Building Trust and Confidence in COVID Vaccines

Facebook's Head of Health KX Jin tells us about the social media giant's campaign to connect users with vaccine information, remove debunked health claims, and support global health agencies.

HOW THE MOTLEY FOOL CAN HELP YOU

Motley Fool Returns

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns

465%

S&P 500 Returns

125%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/06/2023.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Join Stock Advisor

Cumulative Growth of a $10,000 Investment in Stock Advisor

Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.

Chart Showing the Cumulative Growth of a $10,000 Investment in Stock Advisor

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services